Clinical Chemistry

Lab Evidence Confirms Outbreak of Haff Disease
Haff disease is a syndrome of unexplained rhabdomyolysis following consumption of certain types of fish, and it is caused by an unidentified toxin. Rhabdomyolysis is a clinical syndrome caused by injury to skeletal muscle that results in release of muscle cell contents into the circulation. More...28 Jun 2017

Enhanced Immunoassay Validated for NGAL
The ectopic expression of Neutrophil Gelatinase-Associated Lipocalin (NGAL) has been reported in patients with various malignancies such as kidney, colorectal, gastric, pancreatobiliary, hepatic, breast, gynecological and hematologic cancers. More...28 Jun 2017
Cholesterol Test May Help Assess Heart Disease Risk
Researchers have developed a first-of-its-kind rapid assay for measuring effectiveness of a patient’s high-density lipoprotein cholesterol (HDL-C) in cleaning up arterial cholesterol. This HDL-C function test could improve risk assessment and diagnosis, and help provide and monitor more personalized treatments for cardiovascular disease (CVD) patients. More...27 Jun 2017

Specific Biomarker Assessed for Cartilage Degradation
Osteoarthritis (OA) is one of the most common forms of musculoskeletal disorders and one of the major causes of pain and disability in the adult population. Viscosupplementation is a symptomatic treatment of the knee osteoarthritis based on the intra-articular injection of hyaluronic acid (IAHA). More...21 Jun 2017
Pre-Op Cholesterol Level Predicts RCC Patients Survival
Renal cell carcinoma (RCC) is the most frequently diagnosed renal malignancy. The constant advances of modern imaging technologies and the percentage of incidentally detected renal tumors has constantly increased during the last couple of decades, and a good percentage of patients are still diagnosed with metastatic renal cell carcinoma (mRCC). More...21 Jun 2017

POC Analyzer Compared with HPLC Method
The measurement of the glycated fraction of hemoglobin (HbA1c) has been recommended to diagnose diabetes, in addition to monitoring glycemic control. HbA1c reflects long-term glycemic control over the preceding two to three months as opposed to glycemic control at a single point in time. More...20 Jun 2017

Blood Test Offers Improved Breast Cancer Detection
Breast cancer is predicted to be the second leading cause of cancer deaths in the USA women. Approximately 232,000 cases of invasive breast cancer and 60,000 cases of ductal carcinoma in situ (DCIS) are diagnosed and 40,000 deaths occur annually. More...16 Jun 2017
In Other News
Cardiac Troponin Test Uses Single Molecule Counting Technology
Thyroid Disorders Affect Circulating TRAIL Levels
Baby Teeth Reveal Association Between Autism and Metals
Vitamin D Assays Compared and Harmonized
Simple Urine Test Helps Patients with COPD
Sensors Developed to Detect Disease Markers in Breath
Simple Blood Tests Improve Hypertension Treatment
Glioma Risk Lower with Elevated Blood Sugar
BK Virus Biomarkers Determined by Urine Samples
New Test May Predict Gestational Diabetes Better
Prognostic Tool Stratifies Risk of Parathyroid Carcinoma
Smart Pills Offer Diagnostic Tool for Gut Disorders
Cardiac Troponin Assay Compared with Existing Tests
Link Discovered Between Strep Infections and Blood Type
Blood Test Could Detect Abusive Head Trauma in Infants
Lab-On-A-Chip Designed to Minimize Preterm Births
Urinary Volatiles Tested for Prostate Cancer Diagnosis
Thyroid Hormone Level Identifies Risk of Atherosclerosis
Extra Tests Help Screen High-Risk Children for Diabetes
New Recommendations Issued for Endocrine Hypertension Screening
All-in-One Test Provides Faster Testing for Persistent Diarrhea
Blood Test Predicts Effectiveness of Depression Medication
Plasma Lipids Associated Differently with Dementia Incidents
The Clinical Chemistry channel updates the reader on tests, techniques, and research in the field - from routine assays to specialized tests on blood, urine, enzymes, lipids, hormones and more.